Goldman (NYSE:GS) Boosts CME Group's (NASDAQ:CME) 4Q Estimate on Increased Volume

Goldman Sachs (NYSE:GS) has a mixed outlook concerning CME Group (NASDAQ:CME), as the volume and margins look good going forward, but their exposure to currency fluctuations could keep them performing at high levels.

In the short term Goldman believes they'll outperform, as they raised their EPS estimate for the 4th quarter based on improved volume.

Goldman raised their EPS estimates for the 4Q10, 2010, 2011, and 2012 from $3.70, $15.50, $16.75 and $19.00 to $3.99, $15.80, $17.00, and $19.25.

Goldman maintains their "Neutral" rating on CME, which closed Monday at $326.21, up $1.95, or 0.60 percent. Goldman raised their price target on CME from to $340.